IMDX
Insight Molecular DiagnosticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
IMDX vs peer average
52/100
IMDX vs. peer average (C vs. C)
Grade spread
A 2 · B 2 · C 1 · D 3 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
CABA is the first available peer comparator.
Small-cap biotech peer for capital-markets dependence and binary catalyst trading, though its therapeutic focus is not directly comparable to IMDX's diagnostics path.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
IMDX
Insight Molecular Diagnostics
CABA
Cabaletta Bio
Grade
C
B
Momentum
97
89
Value
41
41
Sentiment
6
47
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs CABA
IMDX / CABA
Grade Position
In line
IMDX vs. peer average (C vs. C)
52/100
Momentum
97
IMDXValue
41
IMDXSentiment
6
CABARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs IMDX
CABA is the first peer returned for this comparison set.